Assessing Promising NASH Compounds
Carol Tomaszewski2021-08-31T10:52:03-05:00Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation, cell injury and fibrosis. Progression of this [...]
Liver Steatosis: 2D and 3D Screening Platforms
Griffin Ferrara2021-06-05T18:09:58-05:00Steatosis is characterized by abnormal retention of lipids within an organ and is most common within the liver due to [...]
PHH, HepG2 or HepaRG for Drug Induced Liver Injury Studies?
Griffin Ferrara2020-11-30T14:35:00-05:00Drug-induced liver injury (DILI) is one of the most frequent causes of safety-related drug marketing withdrawal, according to the [...]